By MELISSA LUNARDI The Rise of Digital Grief Support We’re witnessing a shift in how we process one of humanity’s most universal experiences: grief. Several companies have emerged in recent years to develop grief-related technology, where users can interact with AI versions of deceased loved ones or turn to general AI platforms for grief support….
FDA approval of Merck’s RSV antibody drug, Enflonsia, makes it a direct competitor to Sanofi’s Beyfortus. The new Merck product is expected to be discussed by the CDC’s Advisory Committee on Immunization Practices; ACIP will have an entirely new roster at its next meeting after all 17 sitting members were dismissed by Health and Human…
GoodRx launched Community Link, a new cost-plus pricing program that allows independent pharmacies to contract directly with GoodRx. The post GoodRx Unveils Cost-Plus Model for Independent Pharmacies appeared first on MedCity News.
The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least half of the security council’s staff have been laid off or left. This is dangerous say former health security officials. The post In Axing mRNA Contract, Trump…
The technologies and techniques developed for eye transplantation and nerve regeneration may have significant translational potential for other biomedical needs including: spinal cord injury, central nervous system regeneration, retinal cell and tissue transplantation, and other forms of organ and tissue transplantation. The post Whole Eye Transplantation is No Longer Just Science Fiction appeared first on…
Novo Nordisk, AbbVie, and Roche each have weekly injectable drug candidates designed to bind to and activate the amylin receptor to trigger weight loss. Metsera’s contender, MET-233i, is designed with technology that enables longer dosing intervals and the company is proceeding with development of this engineered peptide as a monotherapy and as part of a…
EMS data is often the earliest signal of a looming public health crisis. By tapping into it in real time, agencies can detect overdose spikes, respiratory surges, or behavioral health trends days before traditional systems catch up. The post The Hidden Frontline of Public Health: How EMS Data Is Powering a New Era of Syndromic…
[Sponsored] A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices. The post Navina’s AI Copilot Eases the Value-Based Burden, Study Shows appeared first on MedCity News.
The ability to harness real-world insights at scale empowers life sciences companies and clinicians to develop more targeted therapies, improve patient outcomes, and drive evidence-based innovation in BPH treatment. The post Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia appeared first on MedCity News.
Hundreds of workers at the National Institutes of Health on Monday openly protested the Trump administration’s cuts to the agency and consequences for human lives, writing in a sharply worded letter that its actions are causing “a dramatic reduction in life-saving research.” In a June 9 letter to NIH Director Jay Bhattacharya, NIH workers said…